Long-Term Follow-Up of Children With Congenital Hyperinsulinism on Octreotide Therapy


Demirbilek H., Shah P., Arya V. B. , Hinchey L., Flanagan S. E. , Ellard S., ...More

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol.99, no.10, pp.3660-3667, 2014 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 99 Issue: 10
  • Publication Date: 2014
  • Doi Number: 10.1210/jc.2014-1866
  • Journal Name: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.3660-3667

Abstract

Context: Octreotide, a somatostatin analog, is commonly used in diazoxide unresponsive congenital hyperinsulinism (CHI) patients as a second-line therapy.